userPhoto

Dr. Norman Greenberg, PhD

Position
Senior Vice President and Chief Scientific Officer
Location
Redwood City, CA, US
Bio
Dr. Greenberg was previously Senior Vice President for Translational Medicine at Checkmate Pharmaceuticals, where he helped bring innovative immuno-oncology combinations to the clinic. Prior to Checkmate, Dr. Greenberg was Vice President of Global Research, Oncology, at MedImmune (AstraZeneca), where he spearheaded global research activities for immune-mediated and tumor-targeted therapies, a number of which (targeting PDL1, OX40, CD73) have advanced in the clinic. He previously had served as Senior Director of Research, Oncology, at Pfizer, as a Full Member of the Fred Hutchinson Cancer Research Center in Seattle, and as a tenured Professor at Baylor College of Medicine in Houston. Dr. Greenberg received a BSc in microbiology and immunology from the University of Toronto and a PhD in microbiology and immunology from the University of British Columbia. He performed postdoctoral research at Baylor College of Medicine in Houston.
Interests
None yet.